Kyle J Popovich1, Stephanie N Thiede2, Chad Zawitz3, Alla Aroutcheva1, Darjai Payne4, William Janda5, Michael Schoeny6, Stefan J Green7, Evan S Snitkin8, Robert A Weinstein1. 1. Section of Infectious Diseases, Rush University Medical Center/Cook County Health, Chicago, IL, USA. 2. Department of Microbiology and Immunology, University of Michigan, Chicago, IL, USA. 3. Section of Infectious Diseases, Stroger Hospital of Cook County/Cermak Health Services, Chicago, IL, USA. 4. Section of Infectious Diseases, Rush University Medical Center, Chicago, IL, USA. 5. Department of Pathology, Stroger Hospital of Cook County, Chicago, IL, USA. 6. College of Nursing, Community Systems and Mental Health Nursing, Rush University Medical Center, Chicago, IL, USA. 7. Director, DNA Services Facility, University of Illinois at Chicago, Chicago, IL, USA. 8. Department of Microbiology and Immunology, Department of Medicine, Division of Infectious Diseases, University of Michigan, Ann Arbor, MI, USA.
Abstract
BACKGROUND: Congregate settings, such as jails, may be a location where colonized detainees transmit methicillin-resistant Staphylococcus aureus (MRSA). We examined MRSA acquisition during incarceration and characterized the genomic epidemiology of MRSA entering the jail and isolated during incarceration. METHODS: Males incarcerated at the Cook County Jail were enrolled within 72 h of intake and MRSA surveillance cultures collected. Detainees in jail at Day 30 were re-cultured to determine MRSA acquisition. A survey was administered to identify acquisition predictors. Genomic sequencing of surveillance and clinical isolates was integrated with epidemiologic and jail location data to track MRSA transmission pathways. RESULTS: 800 males were enrolled; 19% MRSA colonized at intake. Of 184 who reached Day 30 visit, 12 acquired MRSA. Heroin use before entering (OR 3.67, P = .05) and sharing personal items during incarceration (OR = 4.92, P = .01) were predictors of acquisition. Sequenced clinical USA300 isolates (n = 112) were more genetically similar than diverse intake USA300 strains (P < .001), suggesting jail transmission. Four acquired colonization isolates were within 20 single-nucleotide variant (SNVs) of other isolates; 4 were within 20 SNVs of an intake isolate, 2 for an acquisition isolate, and 1 for a clinical isolate. Individuals with genetically similar isolates were more likely to have had overlapping stays in the same buildings. CONCLUSION: There was a high MRSA burden entering jail. Genomic analysis of acquisition and clinical isolates suggests potential spread of incoming strains and networks of spread during incarceration, with spread often occurring among detainees housed in similar locations. Sharing personal items during incarceration is associated with MRSA acquisition and could be a focus for intervention.
BACKGROUND: Congregate settings, such as jails, may be a location where colonized detainees transmit methicillin-resistant Staphylococcus aureus (MRSA). We examined MRSA acquisition during incarceration and characterized the genomic epidemiology of MRSA entering the jail and isolated during incarceration. METHODS: Males incarcerated at the Cook County Jail were enrolled within 72 h of intake and MRSA surveillance cultures collected. Detainees in jail at Day 30 were re-cultured to determine MRSA acquisition. A survey was administered to identify acquisition predictors. Genomic sequencing of surveillance and clinical isolates was integrated with epidemiologic and jail location data to track MRSA transmission pathways. RESULTS: 800 males were enrolled; 19% MRSA colonized at intake. Of 184 who reached Day 30 visit, 12 acquired MRSA. Heroin use before entering (OR 3.67, P = .05) and sharing personal items during incarceration (OR = 4.92, P = .01) were predictors of acquisition. Sequenced clinical USA300 isolates (n = 112) were more genetically similar than diverse intake USA300 strains (P < .001), suggesting jail transmission. Four acquired colonization isolates were within 20 single-nucleotide variant (SNVs) of other isolates; 4 were within 20 SNVs of an intake isolate, 2 for an acquisition isolate, and 1 for a clinical isolate. Individuals with genetically similar isolates were more likely to have had overlapping stays in the same buildings. CONCLUSION: There was a high MRSA burden entering jail. Genomic analysis of acquisition and clinical isolates suggests potential spread of incoming strains and networks of spread during incarceration, with spread often occurring among detainees housed in similar locations. Sharing personal items during incarceration is associated with MRSA acquisition and could be a focus for intervention.
Authors: Jennifer Broad; Tamara Cox; Sergio Rodriguez; Mohamed Mansour; Concetta Mennella; Dorothy Murphy-Swallow; John M Raba; William Wong Journal: Sex Transm Dis Date: 2009-02 Impact factor: 2.830
Authors: Scott K Fridkin; Jeffrey C Hageman; Melissa Morrison; Laurie Thomson Sanza; Kathryn Como-Sabetti; John A Jernigan; Kathleen Harriman; Lee H Harrison; Ruth Lynfield; Monica M Farley Journal: N Engl J Med Date: 2005-04-07 Impact factor: 91.245
Authors: J Merrer; F Santoli; C Appéré de Vecchi; B Tran; B De Jonghe; H Outin Journal: Infect Control Hosp Epidemiol Date: 2000-11 Impact factor: 3.254
Authors: Michael W Ellis; Duane R Hospenthal; David P Dooley; Paula J Gray; Clinton K Murray Journal: Clin Infect Dis Date: 2004-09-02 Impact factor: 9.079
Authors: Jason E Farley; Tracy Ross; Paul Stamper; Sharon Baucom; Elaine Larson; Karen C Carroll Journal: Am J Infect Control Date: 2008-10-03 Impact factor: 2.918
Authors: Kyle J Popovich; Stephanie N Thiede; Chad Zawitz; Darjai Payne; Alla Aroutcheva; Michael Schoeny; Stefan J Green; Evan S Snitkin; Robert A Weinstein; Darjai Payne Journal: Open Forum Infect Dis Date: 2022-01-31 Impact factor: 4.423